MARKET

BYSI

BYSI

Beyondspring Inc
NASDAQ
0.6654
+0.0252
+3.94%
After Hours: 0.6404 -0.025 -3.76% 18:47 08/28 EDT
OPEN
0.6100
PREV CLOSE
0.6402
HIGH
0.6699
LOW
0.6100
VOLUME
114.24K
TURNOVER
--
52 WEEK HIGH
2.440
52 WEEK LOW
0.5657
MARKET CAP
27.36M
P/E (TTM)
-4.0623
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 2d ago
Weekly Report: what happened at BYSI last week (0817-0821)?
Weekly Report · 5d ago
Weekly Report: what happened at BYSI last week (0810-0814)?
Weekly Report · 08/17 09:58
BeyondSpring GAAP EPS of -$0.02
Seeking Alpha · 08/17 08:32
Press Release: BeyondSpring Reports -2-
Dow Jones · 08/14 21:15
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 08/14 12:06
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/14 08:37
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 08/13 21:06
More
About BYSI
BeyondSpring Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to improve clinical outcomes for patients with high unmet medical needs. Its lead asset, Plinabulin, is in late-stage clinical development as an anti-cancer agent in non-small cell lung cancer (NSCLC) and a range of cancer indications. The Company’s mechanism of action as a dendritic cell maturation agent supports both anti-cancer activity and immune modulation, offering an approach to resensitizing tumors to checkpoint inhibitors. It also has a pipeline of immuno-oncology product candidates, BPI-002 program, which is based on an oral small molecule agent that increases T-cell co-stimulation; BPI-003 program, which is based on a small molecule inhibitor of IKK, a protein kinase, and BPI-004 program, which is focused on a small molecule that induces the production of neo-antigens by tumor cells, allowing tumors containing no immune cells to be infiltrated by the immune system.

Webull offers Beyondspring Inc stock information, including NASDAQ: BYSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BYSI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BYSI stock methods without spending real money on the virtual paper trading platform.